HomeMedical SpecialtiesCardiologyFirst-in-Canada implant of novel sensor device for heart failure patients

First-in-Canada implant of novel sensor device for heart failure patients

Published on

By Lianne Castelino and Erica Ngao

In a Canadian first, an interventional cardiology team at the Peter Munk Cardiac Centre (PMCC), in collaboration with the Ted Rogers Centre for Heart Research (TRCHR), has implanted a wireless device inside a heart failure patient, enabling clinicians to proactively monitor a patient’s cardiovascular status—virtually and in real-time—with the goal to reduce hospitalizations and re-admissions to hospital, improve quality of life and ultimately, survival.

The device called CardioMEMS HF System, developed by Abbott, was implanted in a 40-year-old male patient in March 2017 at PMCC.

Diagnosed with heart failure as a result of a heart attack in 2016, the patient, who did not want to be identified by name, underwent an angioplasty (a procedure to widen narrowed or obstructed arteries or veins) at PMCC last year, and was found to have left ventricular dysfunction, weakened heart muscle and coronary artery disease—the most common cause of heart failure.

“Heart failure is an epidemic that commonly leads to hospitalization,” says Dr. Heather Ross, scientific lead at the Ted Rogers Centre for Heart Research and cardiologist, Peter Munk Cardiac Centre.

“Hospitalization is often necessary when patients start to retain fluid, develop congestion and experience shortness of breath. This technology is a way to directly measure how much fluid is in a patient, allowing us to intervene before they develop symptoms of congestion, before they end up in hospital. This is a big game-changer,” says Dr. Ross.

In a Canadian first at the Peter Munk Cardiac Centre, in collaboration with the Ted Rogers Centre for Heart Research, a medical team has implanted a wireless device inside a heart failure patient, permitting clinicians to monitor the patient’s cardiovascular status – virtually and in real-time. (Courtesy: Peter Munk Cardiac Centre)

The CardioMEMS HF System features a small butterfly-like sensor that is implanted, via a catheter-based procedure, into the pulmonary artery (which carries blood from the right ventricle of the heart to the lungs) of a heart failure patient. When the patient lies on an accompanying antenna-equipped pillow device, the sensor provides important data – including the patient’s lung pressure readings to clinicians – to a secure website.

“It’s going to give us invasive data that we can’t get any other way apart from having the patient in the hospital and having an invasive test to get the information,” says Meredith Linghorne, Nurse Practitioner, Heart Failure, PMCC.

“This way we’re getting crucial information about how the patient is doing and we can get it while they’re at home. It will give us pulmonary artery pressure readings that we use to help decide how well someone with heart failure is doing from a volume perspective. If their pressure readings are very high, it suggests that they’re retaining fluid and we need to make adjustments to their medications,” she says.

The patient is the first among 25 to be fitted with the device over the next nine months. The device is designed for a specific group of heart failure patients—those in serious condition but who are not so ill that the technology can’t improve their outcome.

The device was the subject of the CHAMPION trial in the United States and has been approved by the Food and Drug Administration (FDA) in the U.S.  Efforts are underway to seek approval for the device from Health Canada.

Lianne Castelino and Erica Ngao are communication officers at University Health Network.

 ABOUT HEART FAILURE:

The most rapidly rising cardiovascular disease in Canada

1 million  – Canadians diagnosed

26 million – Global heart failure patients

10 days – average length of hospital stay

1.4 million – total number of hospital stays in Canada for heart failure

2.1 – average life span of heart failure patient after diagnosis

$3 billion – cost to Canadian health-care system

25% – # of heart failure patients who return to hospital within 3 months

50% – heart failure patients who return to hospital within 6 months

 

 

Latest articles

A pathway to independence for patients with rare disease

Nearly 20 years ago, Audrey Gouskos came through the St. Michael’s Hospital Emergency Department...

Robotic-assisted rehabilitation now available in Fraser Health

Stroke patient Leanne Mork is learning to walk again with the assistance of a...

Helping Canada Design Health Care Facilities for Future Needs

Health care facilities (HCFs) play an important role in communities, providing a safe, secure,...

AI innovation unlocks non-surgical way to detect brain cancer spread

In new study, MRI combined with machine learning reveals presence of cancer cells with...

More like this

Free toolkit to support mental health in the workplace

The Canadian Centre for Occupational Health and Safety (CCOHS) has released a free Workplace Mental...

Move more, age well: prescribing physical activity for older adults as a recipe for healthy aging

Can physical activity extend the lifespans of older adults? A review article published in CMAJ (Canadian...

Antipsychotic use has been rising in long-term care homes, but we can do something about it – we’ve done it before

As health care providers working in long-term care (LTC), we’ve seen firsthand how antipsychotic...

Sinai Health team sheds light on COVID-19 variant dynamics in Toronto

The worst days of the pandemic may be behind us, but research into the...

Safe medication use of blood thinning medications

blood clot is an accumulation of blood that has thickened and clumped together. The...

Canadian first: Sunnybrook achieves second level of age-friendly health system designation

Sunnybrook Health Sciences Centre is proud to announce a first-in-Canada recognition, as we received...